Dietary flavonoids modulate the gut microbiota: A new perspective on improving autism spectrum disorder through the gut-brain axis

Food Res Int. 2024 Jun:186:114404. doi: 10.1016/j.foodres.2024.114404. Epub 2024 Apr 21.

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder with an unknown etiology. It is associated with various factors and causes great inconvenience to the patient's life. The gut-brain axis (GBA), which serves as a bidirectional information channel for exchanging information between the gut microbiota and the brain, is vital in studying many neurodegenerative diseases. Dietary flavonoids provide anti-inflammatory and antioxidant benefits, as well as regulating the structure and function of the gut microbiota. The occurrence and development of ASD are associated with dysbiosis of the gut microbiota. Modulation of gut microbiota can effectively improve the severity of ASD. This paper reviews the links between gut microbiota, flavonoids, and ASD, focusing on the mechanism of dietary flavonoids in regulating ASD through the GBA.

Keywords: Bioavailability; Gut microbiome; Inflammation; Mechanism; Neurodegenerative disease; Oxidative stress; Prebiotics.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Autism Spectrum Disorder* / diet therapy
  • Autism Spectrum Disorder* / metabolism
  • Autism Spectrum Disorder* / microbiology
  • Brain / metabolism
  • Brain-Gut Axis*
  • Diet
  • Dysbiosis
  • Flavonoids* / pharmacology
  • Gastrointestinal Microbiome* / drug effects
  • Humans

Substances

  • Flavonoids
  • Antioxidants